Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Piperonylic acid may help hair growth and treat hair loss.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Minoxidil nanoparticles can potentially be a more effective treatment for hair growth than current treatments.

Targeting the Smoothened receptor shows promise for treating certain cancers.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Royal jelly can protect the heart from damage caused by paclitaxel.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

FR-1 reduces skin scarring and promotes healing without harmful effects.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Ritlecitinib works well and is safe for treating alopecia areata.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

P2X₃-IR fibers are widespread in rat skin and likely help detect pain.

SIG-1451 could be a promising new treatment for atopic dermatitis.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.